PSTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PSTX shares is 134, representing 58.44% of the company's common stock.

BLACKROCK INC., in the last quarter, reduced its stake in PSTX by -1.61% restricting it's holding to 4.95 million shares of worth nearly $15.79M. SILVERARC CAPITAL MANAGEMENT, LLC also lessened -2.95% of the PSTX shares from its portfolio, reducing its holding to 3.6 million shares of worth $11.47M. BANK OF NEW YORK MELLON CORP also shunned PSTX shares holding by -11.99% last quarter which brought its holding to 202.38 thousand shares worth $645.61K.

As per its latest 13F filing, BALYASNY ASSET MANAGEMENT L.P. increased its stake in PSTX by 100% in the last quarter. The institutional holder raised its holding to 56.84 thousand shares having worth more than $181.31K. CITIGROUP INC also added 30.76% more shares of PSTX to its portfolio, raising its holding to 12.85 thousand shares of worth $41.00K. PROSHARE ADVISORS LLC also increased its PSTX shares holding by 8.53% which brought its holding to 12.21 thousand shares worth $38.95K.

The insider with the most stakes in PSTX is Malin Life Sciences Holdings Ltd , at the company. Additionally, PSTX stock is highly held by 10 percent owner KINDERHOOK, LP and director Hirsch David among others.

Company executives, directors, and other insiders own 27.64% percent of Poseida Therapeutics, Inc.'s stock. Within the last six months, there have been 2 transaction(s) in which PSTX insiders have sold stock, totaling 60K shares. Insiders that have sold shares include GERGEN MARK J, OSTERTAG ERIC, and SPEAR MATTHEW A..

There have been 0 transaction(s) during the past 6-months in which Poseida Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 1.3M Poseida Therapeutics, Inc. shares are held by insiders, which represents about 27.64% of PSTX stock.

PSTX , Malin Life Sciences Holdings Ltd holds the largest portfolio of the company's shares. PSTX shares owned by Malin total nearly 11.84 million.

BALYASNY ASSET MANAGEMENT L.P. is the largest institutional owner in PSTX which holds 56.84 thousand shares worth $181.31K or 0.06% of the total PSTX shares outstanding followed by CITIGROUP INC with ownership of 12.85 thousand shares representing 0.01% of the PSTX ownership. PROSHARE ADVISORS LLC is the third largest stakeholder with 12.21 thousand shares or 0.01% of the ownership worth more than $38.95K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PSTX is concerned, it is a stock which is optionable.

Number of PSTX shares short is 3.59M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 97.47M shares of PSTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PSTX has 64.70M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PSTX is 1.49.